A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Condition: Relapsed or Refractory Multiple Myeloma Interventions: Drug: Cevostamab; Drug: Elranatamab; Drug: Tocilizumab Sponsor: Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
Conditions: COVID-19; Hospitalized COVID-19 Patients Interventions: Drug: Lopinavir / Ritonavir; Drug: Remdesivir (RDV); Drug: Tocilizumab; Other: Corticosteroid Therapy-enhanced Standard Care (CTSC) Sponsors: Lebanese University; Hospital Saydet Zgharta University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials